Silicon bioceramic loaded with vancomycin stimulates bone tissue regeneration.

Established knowledge shows that β-tricalcium phosphate (β-TCP) is a widely used bone graft material due to its osteoconductive properties. However, the need to enhance bone regeneration while preventing infection remains unmet. Prior research has shown that silicon-doped ceramics can improve osteoblast activity and porosity, but the comparative effectiveness of silicon-doped versus pure β-TCP in bone regeneration is not fully understood. No prior work had resolved how silicon doping affects vancomycin release profiles or bone formation rates. This gap motivated the investigation of silicon-doped β-TCP as a potential scaffold material. The study aimed to address these uncertainties by comparing silicon-doped and pure β-TCP ceramics. The lack of clarity around drug release behavior and bone formation rates in these materials created a need for new data. The absence of a clear link between ceramic microstructure and bone regeneration outcomes also drove the research. This study sought to clarify how silicon doping influences both structural and biological properties of β-TCP scaffolds.

The study aimed to compare the bone regeneration potential of silicon-doped β-TCP (Si-β-TCP) and pure β-TCP ceramics. The specific problem addressed was whether silicon doping improves porosity, cell viability, and bone formation compared to pure β-TCP. The motivation stemmed from the need to develop a scaffold that supports rapid bone regeneration while delivering antibiotics. The study also aimed to evaluate vancomycin release characteristics from these materials. Researchers hypothesized that Si-β-TCP would outperform pure β-TCP in promoting bone growth. The motivation was to create a material that supports both tissue regeneration and infection prevention. The study sought to validate the hypothesis through in vitro and in vivo experiments. The ultimate goal was to provide a scientific basis for using Si-β-TCP in clinical bone regeneration applications.

The study utilized high-pressure mercury porosimetry to assess internal pore distribution and porosity in both Si-β-TCP and pure β-TCP ceramics. The Brunauer-Emmett-Teller (BET) method was applied to measure specific surface area. Human osteoblast-like MG-63 cells were cultured on the materials to evaluate proliferation and viability. Eight New Zealand rabbits received 10 mm calvarial defects implanted with the ceramic materials. After 8 and 12 weeks, histological and histomorphometric analyses were conducted. Vancomycin hydrochloride was loaded into the ceramics, and burst release was measured. Bacterial inhibition was tested to assess antimicrobial efficacy. The experimental design included both in vitro and in vivo components to evaluate structural and biological properties.

Si-β-TCP demonstrated higher porosity and specific surface area compared to pure β-TCP. Cytocompatibility tests showed acceptable proliferation and viability of MG-63 cells on both materials. Histomorphometric analysis revealed a higher percentage of new bone formation in Si-β-TCP at 12 weeks (p < 0.05). The two-time study confirmed statistically significant differences in bone regeneration. Vancomycin-loaded Si-β-TCP showed burst release within the first 24 hours. The material exhibited the ability to inhibit bacterial growth effectively. Histological results supported the histomorphometric findings, showing enhanced bone formation in Si-β-TCP. The study demonstrated that silicon doping enhances both structural and biological properties of β-TCP scaffolds.

The authors concluded that Si-β-TCP outperformed pure β-TCP in terms of porosity and specific surface area. The study suggests that Si-β-TCP supports better bone regeneration, as evidenced by higher new bone formation at 12 weeks. Vancomycin-loaded Si-β-TCP showed effective burst release and antimicrobial activity. The findings propose that silicon doping enhances the osteoconductive properties of β-TCP. The study does not claim that Si-β-TCP is essential for bone regeneration but suggests it may be a promising option. The results indicate that Si-β-TCP could be a suitable material for bone tissue engineering applications. The authors do not state that Si-β-TCP is the only viable option but suggest it may offer advantages over pure β-TCP. The conclusions are based on the observed differences in porosity, cell viability, and bone formation rates.